table of content
1 Introduction to Research & Analysis Reports
1.1 Pharmaceutical CDMO Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmaceutical CDMO Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmaceutical CDMO Services Overall Market Size
2.1 Global Pharmaceutical CDMO Services Market Size: 2022 VS 2029
2.2 Global Pharmaceutical CDMO Services Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharmaceutical CDMO Services Players in Global Market
3.2 Top Global Pharmaceutical CDMO Services Companies Ranked by Revenue
3.3 Global Pharmaceutical CDMO Services Revenue by Companies
3.4 Top 3 and Top 5 Pharmaceutical CDMO Services Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pharmaceutical CDMO Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmaceutical CDMO Services Players in Global Market
3.6.1 List of Global Tier 1 Pharmaceutical CDMO Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmaceutical CDMO Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pharmaceutical CDMO Services Market Size Markets, 2022 & 2029
4.1.2 Drug Substance Development and Manufacturing
4.1.3 Specialized Services
4.1.4 Lab-based Services
4.2 By Type - Global Pharmaceutical CDMO Services Revenue & Forecasts
4.2.1 By Type - Global Pharmaceutical CDMO Services Revenue, 2018-2023
4.2.2 By Type - Global Pharmaceutical CDMO Services Revenue, 2024-2029
4.2.3 By Type - Global Pharmaceutical CDMO Services Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pharmaceutical CDMO Services Market Size, 2022 & 2029
5.1.2 Innovative Medicine
5.1.3 Patented Drug
5.1.4 Patent Expired Drug
5.2 By Application - Global Pharmaceutical CDMO Services Revenue & Forecasts
5.2.1 By Application - Global Pharmaceutical CDMO Services Revenue, 2018-2023
5.2.2 By Application - Global Pharmaceutical CDMO Services Revenue, 2024-2029
5.2.3 By Application - Global Pharmaceutical CDMO Services Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Pharmaceutical CDMO Services Market Size, 2022 & 2029
6.2 By Region - Global Pharmaceutical CDMO Services Revenue & Forecasts
6.2.1 By Region - Global Pharmaceutical CDMO Services Revenue, 2018-2023
6.2.2 By Region - Global Pharmaceutical CDMO Services Revenue, 2024-2029
6.2.3 By Region - Global Pharmaceutical CDMO Services Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Pharmaceutical CDMO Services Revenue, 2018-2029
6.3.2 US Pharmaceutical CDMO Services Market Size, 2018-2029
6.3.3 Canada Pharmaceutical CDMO Services Market Size, 2018-2029
6.3.4 Mexico Pharmaceutical CDMO Services Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Pharmaceutical CDMO Services Revenue, 2018-2029
6.4.2 Germany Pharmaceutical CDMO Services Market Size, 2018-2029
6.4.3 France Pharmaceutical CDMO Services Market Size, 2018-2029
6.4.4 U.K. Pharmaceutical CDMO Services Market Size, 2018-2029
6.4.5 Italy Pharmaceutical CDMO Services Market Size, 2018-2029
6.4.6 Russia Pharmaceutical CDMO Services Market Size, 2018-2029
6.4.7 Nordic Countries Pharmaceutical CDMO Services Market Size, 2018-2029
6.4.8 Benelux Pharmaceutical CDMO Services Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Pharmaceutical CDMO Services Revenue, 2018-2029
6.5.2 China Pharmaceutical CDMO Services Market Size, 2018-2029
6.5.3 Japan Pharmaceutical CDMO Services Market Size, 2018-2029
6.5.4 South Korea Pharmaceutical CDMO Services Market Size, 2018-2029
6.5.5 Southeast Asia Pharmaceutical CDMO Services Market Size, 2018-2029
6.5.6 India Pharmaceutical CDMO Services Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Pharmaceutical CDMO Services Revenue, 2018-2029
6.6.2 Brazil Pharmaceutical CDMO Services Market Size, 2018-2029
6.6.3 Argentina Pharmaceutical CDMO Services Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmaceutical CDMO Services Revenue, 2018-2029
6.7.2 Turkey Pharmaceutical CDMO Services Market Size, 2018-2029
6.7.3 Israel Pharmaceutical CDMO Services Market Size, 2018-2029
6.7.4 Saudi Arabia Pharmaceutical CDMO Services Market Size, 2018-2029
6.7.5 UAE Pharmaceutical CDMO Services Market Size, 2018-2029
7 Pharmaceutical CDMO Services Companies Profiles
7.1 Recipharm AB
7.1.1 Recipharm AB Company Summary
7.1.2 Recipharm AB Business Overview
7.1.3 Recipharm AB Pharmaceutical CDMO Services Major Product Offerings
7.1.4 Recipharm AB Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.1.5 Recipharm AB Key News & Latest Developments
7.2 AMRI Global
7.2.1 AMRI Global Company Summary
7.2.2 AMRI Global Business Overview
7.2.3 AMRI Global Pharmaceutical CDMO Services Major Product Offerings
7.2.4 AMRI Global Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.2.5 AMRI Global Key News & Latest Developments
7.3 Patheon N.V.
7.3.1 Patheon N.V. Company Summary
7.3.2 Patheon N.V. Business Overview
7.3.3 Patheon N.V. Pharmaceutical CDMO Services Major Product Offerings
7.3.4 Patheon N.V. Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.3.5 Patheon N.V. Key News & Latest Developments
7.4 Aenova Group
7.4.1 Aenova Group Company Summary
7.4.2 Aenova Group Business Overview
7.4.3 Aenova Group Pharmaceutical CDMO Services Major Product Offerings
7.4.4 Aenova Group Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.4.5 Aenova Group Key News & Latest Developments
7.5 Catalent, Inc.
7.5.1 Catalent, Inc. Company Summary
7.5.2 Catalent, Inc. Business Overview
7.5.3 Catalent, Inc. Pharmaceutical CDMO Services Major Product Offerings
7.5.4 Catalent, Inc. Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.5.5 Catalent, Inc. Key News & Latest Developments
7.6 Amatsigroup
7.6.1 Amatsigroup Company Summary
7.6.2 Amatsigroup Business Overview
7.6.3 Amatsigroup Pharmaceutical CDMO Services Major Product Offerings
7.6.4 Amatsigroup Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.6.5 Amatsigroup Key News & Latest Developments
7.7 WuXi AppTec Group
7.7.1 WuXi AppTec Group Company Summary
7.7.2 WuXi AppTec Group Business Overview
7.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Major Product Offerings
7.7.4 WuXi AppTec Group Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.7.5 WuXi AppTec Group Key News & Latest Developments
7.8 Strides Pharma Science Limited
7.8.1 Strides Pharma Science Limited Company Summary
7.8.2 Strides Pharma Science Limited Business Overview
7.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Major Product Offerings
7.8.4 Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.8.5 Strides Pharma Science Limited Key News & Latest Developments
7.9 Piramal Pharma Solutions
7.9.1 Piramal Pharma Solutions Company Summary
7.9.2 Piramal Pharma Solutions Business Overview
7.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Major Product Offerings
7.9.4 Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.9.5 Piramal Pharma Solutions Key News & Latest Developments
7.10 Siegfried Ltd
7.10.1 Siegfried Ltd Company Summary
7.10.2 Siegfried Ltd Business Overview
7.10.3 Siegfried Ltd Pharmaceutical CDMO Services Major Product Offerings
7.10.4 Siegfried Ltd Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.10.5 Siegfried Ltd Key News & Latest Developments
7.11 Fareva Group
7.11.1 Fareva Group Company Summary
7.11.2 Fareva Group Business Overview
7.11.3 Fareva Group Pharmaceutical CDMO Services Major Product Offerings
7.11.4 Fareva Group Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.11.5 Fareva Group Key News & Latest Developments
7.12 FAMAR Health Care Services
7.12.1 FAMAR Health Care Services Company Summary
7.12.2 FAMAR Health Care Services Business Overview
7.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Major Product Offerings
7.12.4 FAMAR Health Care Services Pharmaceutical CDMO Services Revenue in Global Market (2018-2023)
7.12.5 FAMAR Health Care Services Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
